SEC Form 4 · accession 0000899243-18-008071
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nader Pourhassan
Officer — President and CEO · Director
Period of report
Mar 15, 2018
Accepted (ET)
Mar 20, 2018 · 6:08 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 15, 2018 | A | 221,711 | $0.00 | A | 281,767 | D | |
| Common Stock | Mar 15, 2018 | F | 120,278 | $0.69 | D | 161,489 | D | |
| Common Stock | holding | — | — | — | 15,750 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.